6788 results Sort: Date | Relevance
NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.
Terms and conditions for the National Institute for Health and Care Excellence
Our licence allows individuals, commercial organisations and non-commercial organisations to reuse NICE content free of charge in their publications, products and systems.
Find individual child abuse and neglect recommendations quickly and links to full guideline
Summary of the evidence on buprenorphine prolonged-release subcutaneous injection (Buvidal) for opioid dependence to inform local NHS
How we select the subjects for development into information, advice and guidance
How to partner with NICE for your research.
NICE transparency of spend
Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart
The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided its first piece of advice on the design of a patient preference study.
Medtech innovation briefings (MIBs) are NICE advice. They are designed to support NHS and social care commissioners and staff who are considering...
The information below provides a summary of known issues and upcoming changes related to NICE Evidence Services. This information will be updated...
NICE diagnostics assessment recommendations are prepared by an independent advisory committee called the diagnostics advisory committee. Standing...
How to submit a new medical technology to NICE for guidance
Jobs at NICE. Includes current vacancies, roles, location and salary information.
Non-executive directors Dr Rosie Benneyworth Vice Chair View profile Rosie has been a Non-Executive Director at NICE since January 2016 and Vice
We've been making recommendations on the clinical and cost-effectiveness of cancer drugs through our technology appraisal guidance since 2000. Since
Angelica experienced abuse aged 12. She shares her story and talks about her role in developing NICE guidance.
Evidence-based statements to deliver quality improvements in diagnosis and management of serious eye disorders including cataracts, glaucoma and sight loss
People showing erythema migrans, the characteristic skin rash associated with Lyme disease, can be diagnosed without the need for blood tests, NICE says in new guidance.
These two guidelines set out an antimicrobial prescribing strategy that aims to optimise antibiotic use and reduce antibiotic resistance.
Evidence-based statements to deliver quality improvements in recognising, assessing and responding to abuse and neglect of children and young people under 18
Find out more about the quality standards advisory committee 1 members
We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the fast track appraisal.
The Quality Standards Advisory Committees (QSAC) are independent committees that help to develop our quality standards. We have 3 committees who:...
Everything NICE has said on child abuse and neglect in an interactive flowchart
Everything NICE has said on cataracts in adults in an interactive flowchart
Everything NICE has said on assessing, treating and managing glaucoma in adults in an interactive flowchart
Everything NICE has said on age-related macular degeneration in an interactive flowchart
Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart
Advice on the use of Axumin for functional imaging of prostate cancer recurrence to aid local decision making
NICE is updating its guideline on Alcohol interventions in secondary and further education.
NICE accreditation decisions
Links to our annual reports and business plan
Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...
On this page: Media players Downloadable files Accessibility limitations Browser compatibility Contacting us Conformance date
NICE Annual Conference 2019 9 May 2019, Hilton Manchester Deansgate NICE 2019: Transforming care celebrates 20 years of NICE's commitment to...
We're looking for experienced leaders to chair NICE committees in 2019
Resources for OpenAthens and Knowledge Base administrators
Why seek advice? Our evaluation programmes require certain types of evidence about the technology being appraised. Our advice ensures that your...
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
We provide practical support to Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs) at a local level.
Everything NICE has said on sedation for diagnostic and therapeutic procedures in infants, children and young people in an interactive flowchart
Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart
Evidence-based recommendations on an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis
Take an active role in producing a NICE guideline or quality standard.
Fellows are experience health and social care leaders who are our ambassadors at regional and national levels
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.
Scholarships are one year opportunities to improve quality of care and contribute to your professional development